(Q33383709)

26 July 2017

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms (English)

1 reference

26 July 2017

0 references

Andrew Collins

9

0 references

author name string

Amy V Jones

1

1 reference

26 July 2017

Andrew Chase

2

1 reference

26 July 2017

Richard T Silver

3

1 reference

26 July 2017

David Oscier

4

1 reference

26 July 2017

Katerina Zoi

5

1 reference

26 July 2017

Y Lynn Wang

6

1 reference

26 July 2017

Holger Cario

7

1 reference

26 July 2017

Heike L Pahl

8

1 reference

26 July 2017

Andreas Reiter

10

1 reference

26 July 2017

Francis Grand

11

1 reference

26 July 2017

Nicholas C P Cross

12

1 reference

26 July 2017

language of work or name

English

0 references

publication date

15 March 2009

1 reference

26 July 2017

1 reference

26 July 2017

41

1 reference

26 July 2017

446-449

1 reference

26 July 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/ng.334

26 July 2017

0 references

cites work

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

Genome-wide association study identifies novel breast cancer susceptibility loci

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

A gain-of-function mutation of JAK2 in myeloproliferative disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

Jak2 tyrosine kinase: a true jak of all trades?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

A comparison of bayesian methods for haplotype reconstruction from population genotype data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4120192

Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera

28 July 2018

1 reference

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

21 January 2018

1 reference

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

Genetic complexity of myeloproliferative neoplasms.

21 January 2018

1 reference

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

21 January 2018

1 reference

Multiple newly identified loci associated with prostate cancer susceptibility

21 January 2018

1 reference

Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha.

21 January 2018

1 reference

Disease anticipation in familial myeloproliferative neoplasms

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19287382

12 December 2020

inferred from PubMed ID database lookup

The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19287382

12 December 2020

inferred from PubMed ID database lookup

Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19287382

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NG.334

1 reference

release_y7wtfbimebgq7bychs5sdddf24

26 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y7wtfbimebgq7bychs5sdddf24

24 November 2022

mapped directly with Wikidata item

PMCID

4120192

1 reference

26 July 2017

1 reference